June 23, 2014 |
Facing a double mastectomy and hysterectomy, Eva Moon eased the anxiety with a limerick: I've just had a genetic test And I'm feeling a little depressed It's not just because I'll have menopause But I wasn't quite done with my breasts Humor isn't touted much in clinical trials or in FDA approvals, but when it comes to cancer, laughter is good medicine, according to Moon. A 58-year-old performing artist from Redmond, Wash., with fiery red hair and a sultry voice, Moon spoke at the Eighth Annual Joining FORCEs Conference in Philadelphia last week.
December 16, 2013 |
Your mother or sister has just told you she tested positive for a mutation in one of her BRCA genes, meaning her risk of getting breast or ovarian cancer is much higher than normal. And there is a 50 percent chance you have the same mutation. Do you get yourself tested? All too often, the answer is no, according to a new study by researchers at Fox Chase Cancer Center. The authors interviewed 438 close relatives of 253 women who had shared results of their tests for cancer-causing mutations in the genes, called BRCA1 and BRCA2.
May 28, 2013 |
ESCONDIDO, Calif. - Less than two weeks after Angelina Jolie revealed she'd had a double mastectomy to avoid breast cancer, her aunt died from the disease Sunday. Debbie Martin died at age 61 at a hospital in Escondido, Calif., near San Diego, her husband, Ron Martin, told The Associated Press. Debbie Martin was the younger sister of Jolie's mother, Marcheline Bertrand, whose own death from ovarian cancer in 2007 inspired the surgery that Jolie described in a May 14 op-ed in the New York Times.
April 15, 2013 |
As legal questions go, it is very succinct: Can human genes be patented? To the uninitiated, and at least two judges, it might seem obvious - or absurd. How can you get a patent for human genes? Aren't genes part of the human body, part of nature? Can you get a patent for a human leg or kidney, or the sun or the moon? The U.S. Supreme Court will wrestle with the question of whether human genes are patentable during oral arguments Monday in a case that could have huge implications for people needing cancer testing, scientific researchers, and pharmaceutical organizations, but also agricultural producers, other industries, and, perhaps, individual liberty.
October 18, 2012 |
About three years ago, Fox News correspondent Jennifer Griffin felt an orange-sized lump in her breast while weaning her third child. She figured she had a blocked milk duct or maybe an infection. She never dreamed it could be breast cancer. But she soon discovered that the conventional wisdom about the disease - who gets it, when, and why - does not apply to the aggressive subtype known as "triple negative. " "I thought when you were pregnant and nursing you were protected," recalled Griffin, 43, who blogged about her battle against triple negative cancer at jengriffinblog.blogspot.com.
October 16, 2012
From today through Oct. 17, Philly.com and The Inquirer will mark breast cancer awareness month by publishing a profile a day of transformative moments reported by patients. The series culminates in a special Philly.com/health Inquirer section on Oct. 18, and can be viewed at www.philly.com/breastcancer . "My little Sister, Debbi, was diagnosed with triple negative breast cancer when she was 29 years old and pregnant," said Traci Walters of Texas. "They induced labor about a month early because the tumor was growing so fast because she was pregnant.
May 10, 2012 |
The University of Pennsylvania has received a gift of $25 million to start a research center focused on the treatment and prevention of cancers linked to certain hereditary gene mutations, the Philadelphia institution said Tuesday. The donors behind the Basser Research Center are Jon and Mindy Gray, 1992 Penn graduates. Jon Gray, 42, is global head of real estate and a member of the board at New York investment and advisory firm Blackstone Group The center, to be housed at Penn's Abramson Cancer Center in University City, is named in honor of Mindy Gray's sister, Faith Basser, who died at 44 of ovarian cancer caused by a gene mutation.
November 14, 2011 |
Question: Do you think "prophylactic" mastectomy is rather extreme? Answer: Removal of healthy breast tissue as a prophylactic (preventive) effort to prevent breast cancer from occurring or reoccurring is a controversial but deeply personal decision. There are several varied situations where prophylactic mastectomies are performed: (1) Previous breast cancer in one breast; (2) Strong family history of breast cancer; (3) Presence of the BRCA1 or BRCA2 gene mutation for breast cancer; (4)
October 3, 2011 |
They call themselves "previvors. " Genetic testing revealed they had a high lifetime risk of breast cancer as well as ovarian cancer. Their genetic predisposition sets them apart from other healthy women and from genetically predisposed women who've already been diagnosed with cancer. For some previvors, such as Sandy Cohen of Lafayette Hill, breast cancer had cut a swath through their families. They grew up thinking it was only a matter of time until they, too, followed their mothers and grandmothers into the oncologist's office.
June 6, 2011
Biophosphonate found to cut recurrence of breast cancer Women with early-stage breast cancer who added a bone-strengthening "bisphosphonate" drug to standard treatment reduced their risk of recurrence by about a third, according to a large study by Austrian researchers. Because bone marrow provides a fertile ground for cancer cells released by the breast tumor, a bisphosphonate called zoledronic acid is routinely given to women with late-stage cancer that has spread, or metastasized.